{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:25:53Z","timestamp":1790371553077,"version":"4.1.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12264-019-00378-5","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T20:41:40Z","timestamp":1557261700000},"page":"1073-1084","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["High-Voltage-Activated Calcium Channel in the Afferent Pain Pathway: An Important Target of Pain Therapies"],"prefix":"10.1007","volume":"35","author":[{"given":"Qi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diansan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"key":"378_CR1","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1097\/j.pain.0000000000000719","volume":"157","author":"JM Thakral","year":"2016","unstructured":"Thakral JM, Shi L, Foust JB, Patel KV, Shmerling RH, Bean JF, et al. Pain quality descriptors in community-dwelling older adults with nonmalignant pain. Pain 2016, 157: 2834\u20132842.","journal-title":"Pain"},{"key":"378_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/bja\/aet123","volume":"111","author":"O van Hecke","year":"2013","unstructured":"van Hecke O, Torrance N, Smith BH. Chronic pain epidemiology and its clinical relevance. Br J Anaesth 2013, 111: 13\u201318.","journal-title":"Br J Anaesth"},{"key":"378_CR3","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","volume":"73","author":"CA von Hehn","year":"2012","unstructured":"von Hehn CA, Baron R, Woolf CJ. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 2012, 73: 638\u2013652.","journal-title":"Neuron"},{"key":"378_CR4","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","volume":"152","author":"CJ Woolf","year":"2011","unstructured":"Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011, 152: S2\u201315.","journal-title":"Pain"},{"issue":"4","key":"378_CR5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/pr.57.4.5","volume":"57","author":"William A. Catterall","year":"2005","unstructured":"Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltagegated calcium channels. Pharmacol Rev 2005, 57: 411\u2013425.","journal-title":"Pharmacological Reviews"},{"key":"378_CR6","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1074\/jbc.M208689200","volume":"278","author":"J Arikkath","year":"2003","unstructured":"Arikkath J, Chen CC, Ahern C, Allamand V, Flanagan JD, Coronado R, et al. Gamma 1 subunit interactions within the skeletal muscle L-type voltage-gated calcium channels. J Biol Chem 2003, 278: 1212\u20131219.","journal-title":"J Biol Chem"},{"key":"378_CR7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pneurobio.2015.09.002","volume":"134","author":"H Samuel","year":"2015","unstructured":"Samuel H, Pratt WS, Rees E, Dahimene S, Ferron L, Owen MJ, et al. Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Prog Neurobiol 2015, 134: 36\u201354.","journal-title":"Prog Neurobiol"},{"key":"378_CR8","doi-asserted-by":"crossref","first-page":"a003947","DOI":"10.1101\/cshperspect.a003947","volume":"3","author":"WA Catterall","year":"2011","unstructured":"Catterall WA. Voltage-Gated Calcium Channels. Cold Spring Harb Perspect Biol 2011, 3: a003947.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"378_CR9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/A:1023632419813","volume":"23","author":"DJ Triggle","year":"2003","unstructured":"Triggle DJ. 1,4-Dihydropyridines as calcium channel ligands and privileged structures. Cell Mol Neurobiol 2003, 23: 293\u2013303.","journal-title":"Cell Mol Neurobiol"},{"key":"378_CR10","doi-asserted-by":"crossref","first-page":"a022723","DOI":"10.1101\/cshperspect.a022723","volume":"6","author":"S Rajakulendran","year":"2016","unstructured":"Rajakulendran S, Hanna MG. The Role of Calcium Channels in Epilepsy. Cold Spring Harb Perspect Med 2016, 6: a022723.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"378_CR11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature02588","volume":"429","author":"F Van Petegem","year":"2004","unstructured":"Van Petegem F, Clark KA, Chatelain FC, Minor DL Jr. Structure of a complex between a voltage-gated calcium channel \u03b2-subunit and an \u03b1-subunit domain. Nature 2004, 429: 671\u2013675.","journal-title":"Nature"},{"key":"378_CR12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nn.2712","volume":"14","author":"C Altier","year":"2011","unstructured":"Altier C, Garcia-Caballero A, Simms B, You H, Chen L, Walcher J, et al. The Cav\u03b2 subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels. Nature Neurosci 2011, 14: 173\u2013180.","journal-title":"Nature Neurosci"},{"key":"378_CR13","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bbamem.2012.11.019","volume":"1828","author":"AC Dolphin","year":"2013","unstructured":"Dolphin AC. The \u03b12\u03b4 subunits of voltage-gated calcium channels, Biochim Biophys Acta 2013, 1828: 1541\u20131549.","journal-title":"Biochim Biophys Acta"},{"key":"378_CR14","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1073\/pnas.0908735107","volume":"107","author":"A Davies","year":"2010","unstructured":"Davies A, Kadurin I, Alvarez-Laviada A, Douglas L, Nieto-Rostro M, Bauer CS, et al. The alpha2delta subunits of voltage-gated calcium channels form GPI-anchored proteins, a posttranslational modification essential for function. Proc Natl Acad Sci U S A 2010, 107: 1654\u20131659.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"378_CR15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.1123339","volume":"311","author":"RA Nicoll","year":"2006","unstructured":"Nicoll RA, Tomita S, Bredt DS. Auxiliary subunits assist AMPA-type glutamate receptors. Science 2006, 311: 1253\u20131256.","journal-title":"Science"},{"key":"378_CR16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(01)02038-9","volume":"311","author":"SP Yusaf","year":"2001","unstructured":"Yusaf SP, Goodman J, Pinnock RD, Dixon AL, Lee K. Expression of voltage-gated calcium channel subunits in rat dorsal root ganglion neurons. Neurosci Lett 2001, 311: 137\u2013141.","journal-title":"Neurosci Lett"},{"key":"378_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.03.015","volume":"55","author":"FR Silva","year":"2017","unstructured":"Silva FR, Miranda AS, Santos RPM, Olmo IG, Zamponi GW, Dobransky T, et al. N-type Ca2+ channels are affected by full-length mutant huntingtin expression in a mouse model of Huntington\u2019s disease, Neurobiol Aging 2017, 55: 1\u201310.","journal-title":"Neurobiol Aging"},{"key":"378_CR18","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1152\/jn.00608.2014","volume":"113","author":"SS Murali","year":"2015","unstructured":"Murali SS, Napier AI, Mohammadi SA, Alewood PF, Lewis RJ, MacDonald JC. High-voltage-activated calcium current subtypes in mouse DRG neurons adapt in a subpopulation-specific manner after nerve injury. J Neurophysiol 2015, 113: 1511\u20131519.","journal-title":"J Neurophysiol"},{"key":"378_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3959(01)00436-5","volume":"96","author":"MT Smith","year":"2002","unstructured":"Smith MT, Cabot PJ, Ross FB, Robertson AD, Lewis RJ. The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 2002, 96: 119\u2013127.","journal-title":"Pain"},{"key":"378_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-0102(02)00017-2","volume":"43","author":"H Saegusa","year":"2002","unstructured":"Saegusa H, Matsuda Y, Tanabe T. Effects of ablation of N- and R-type Ca2+ channels on pain transmission. Neurosci Res. 2002, 43: 1\u20137.","journal-title":"Neurosci Res."},{"key":"378_CR21","doi-asserted-by":"crossref","first-page":"9862","DOI":"10.1523\/JNEUROSCI.3446-04.2004","volume":"24","author":"PM Newton","year":"2004","unstructured":"Newton PM, Orr CJ, Wallace MJ, Kim C, Shin HS, Messing RO. Deletion of N-type calcium channels alters ethanol reward and reduces ethanol consumption in mice. J Neurosci 2004, 24: 9862\u20139869.","journal-title":"J Neurosci"},{"issue":"1-2","key":"378_CR22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12031-008-9159-2","volume":"39","author":"Sareh Asadi","year":"2009","unstructured":"Asadi S, Javan M, Ahmadiani A, Sanati MH. Alternative splicing in the synaptic protein interaction site of rat Ca(v)2.2 [alpha (1B)] calcium channels: changes induced by chronic inflammatory pain. J Mol Neurosci 2009, 39: 40\u201348.","journal-title":"Journal of Molecular Neuroscience"},{"key":"378_CR23","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.lfs.2006.06.039","volume":"79","author":"M Umeda","year":"2006","unstructured":"Umeda M, Ohkubo T, Ono J, Fukuizumi T, Kitamura K. Molecular and immunohistochemical studies in expression of voltage-dependent Ca2+ channels in dorsal root ganglia from streptozotocin-induced diabetic mice. Life Sci 2006, 79: 1995\u20132000.","journal-title":"Life Sci"},{"key":"378_CR24","doi-asserted-by":"crossref","unstructured":"Waithe D, Ferron L, Page KM, Chaggar K, Dolphin AC. Beta-subunits promote the expression of Ca(V)2.2 channels by reducing their proteasomal degradation. J Biol Chem 2011, 286: 9598\u20139611.","DOI":"10.1074\/jbc.M110.195909"},{"key":"378_CR25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.pain.2010.12.014","volume":"152","author":"A Boroujerdi","year":"2011","unstructured":"Boroujerdi A, Zeng J, Sharp K, Kim D, Steward O, Luo ZD. Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states. Pain 2011,152: 649\u2013655.","journal-title":"Pain"},{"key":"378_CR26","doi-asserted-by":"crossref","first-page":"8494","DOI":"10.1523\/JNEUROSCI.2982-04.2004","volume":"24","author":"CY Li","year":"2004","unstructured":"Li CY, Song YH, Higuera ES, Luo ZD. Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J Neurosci 2004, 24: 8494\u20138499.","journal-title":"J Neurosci"},{"key":"378_CR27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pain.2006.04.022","volume":"125","author":"CY Li","year":"2006","unstructured":"Li CY, Zhang XL, Matthews EA, Li KW, Kurwa A, Boroujerdi A, et al. Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation. Pain 2006, 125: 20\u201334.","journal-title":"Pain"},{"key":"378_CR28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/BST0380525","volume":"38","author":"CS Bauer","year":"2010","unstructured":"Bauer CS, Rahman W, Tran-van-Minh A, Lujan R, Dickenson AH, Dolphin AC. The anti-allodynic alpha(2)delta ligand pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivo. Biochem Soc Trans 2010, 38: 525\u2013528.","journal-title":"Biochem Soc Trans"},{"key":"378_CR29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.117.014399","volume":"70","author":"SRA Alles","year":"2018","unstructured":"Alles SRA, Smith PA. Etiology and pharmacology of neuropathic pain. Pharmacol Rev 2018, 70: 315\u2013347.","journal-title":"Pharmacol Rev"},{"key":"378_CR30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/mol.108.049981","volume":"75","author":"MJ Sinnegger-Brauns","year":"2009","unstructured":"Sinnegger-Brauns MJ, Huber IG, Koschak A, Wild C, Obermair GJ, Einzinger U, et al. Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol Pharmacol 2009, 75: 407\u2013414.","journal-title":"Mol Pharmacol"},{"issue":"8","key":"378_CR31","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/brain\/awu131","volume":"137","author":"Elena Dragicevic","year":"2014","unstructured":"Dragicevic E, Poetschke C, Duda J, Schlaudraff F, Lammel S, Schiemann J, et al. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. Brain 2014, 137: 2287\u20132302.","journal-title":"Brain"},{"key":"378_CR32","doi-asserted-by":"crossref","unstructured":"Jenkins MA, Christel CJ, Jiao Y, Abiria S, Kim KY, Usachev YM, et al. Ca2+-dependent facilitation of Cav1.3 Ca2+ channels by densin and Ca2+\/calmodulin-dependent protein kinase II. J Neurosci 2010, 30: 5125\u20135135.","DOI":"10.1523\/JNEUROSCI.4367-09.2010"},{"key":"378_CR33","first-page":"97","volume":"33","author":"H Ma","year":"2013","unstructured":"Ma H, Cohen S, Li B, Tsien RW. Exploring the dominant role of Cav1 channels in signalling to the nucleus. Biosci Rep 2013, 33: 97\u2013101.","journal-title":"Biosci Rep"},{"key":"378_CR34","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/mp.2012.71","volume":"17","author":"AS Lee","year":"2012","unstructured":"Lee AS, Ra S, Rajadhyaksha AM, Britt JK, De Jesus-Cortes H, Gonzales KL, et al. Forebrain elimination of cacna1c mediates anxiety-like behavior in mice. Mol Psychiatry 2012, 17: 1054\u20131055.","journal-title":"Mol Psychiatry"},{"issue":"04","key":"378_CR35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1017\/S1461145709990368","volume":"13","author":"Perrine Busquet","year":"2009","unstructured":"Busquet P, Nguyen NK, Schmid E, Tanimoto N, Seeliger MW, Ben-Yosef T, et al. Cav1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype. Int J Neuropsychopharmacol 2010, 13: 499\u2013513.","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"378_CR36","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1172\/JCI20208","volume":"113","author":"MJ Sinnegger-Brauns","year":"2004","unstructured":"Sinnegger-Brauns MJ, Hetzenauer A, Huber IG, Renstr\u00f6m E, Wietzorrek G, Berjukov S, et al. isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca2+ channels. J Clin Invest 2004, 113: 1430\u20131439.","journal-title":"J Clin Invest"},{"key":"378_CR37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuroscience.2011.01.049","volume":"179","author":"JB McCallum","year":"2011","unstructured":"McCallum JB, Wu HE, Tang Q, Kwok WM, Hogan QH. Subtype-specific reduction of voltage-gated calcium current in medium-sized dorsal root ganglion neurons after painful peripheral nerve injury. Neuroscience 2011, 179: 244\u2013255.","journal-title":"Neuroscience"},{"issue":"2","key":"378_CR38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0306-4522(03)00329-4","volume":"120","author":"N.C Clark","year":"2003","unstructured":"Clark NC, Nagano N, Kuenzi FM, Jarolimek W, Huber I, Walter D, et al. Neurological phenotype and synaptic function in mice lacking the CaV1.3 alpha subunit of neuronal L-type voltage-dependent Ca2+ channels. Neuroscience 2003, 120: 435\u2013442.","journal-title":"Neuroscience"},{"issue":"18","key":"378_CR39","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1038\/emboj.2011.249","volume":"30","author":"Alexandre Favereaux","year":"2011","unstructured":"Favereaux A, Thoumine O, Bouali-Benazzouz R, Roques V, Papon MA, Salam SA, et al. Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain. EMBO J 2011, 30: 3830\u20133841.","journal-title":"The EMBO Journal"},{"key":"378_CR40","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1523\/JNEUROSCI.4673-09.2010","volume":"30","author":"K Wankerl","year":"2010","unstructured":"Wankerl K, Weise D, Gentner R, Rumpf JJ, Classen J. L-type voltage-gated Ca2+ channels: a single molecular switch for long-term potentiation\/long-term depression-like plasticity and activity-dependent metaplasticity in humans. J Neurosci 2010, 30: 6197\u20136204.","journal-title":"J Neurosci"},{"issue":"4","key":"378_CR41","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nn.2504","volume":"13","author":"Daejong Jeon","year":"2010","unstructured":"Jeon D, Kim S, Chetana M, Jo D, Ruley HE, Lin SY, et al. Observational fear learning involves affective pain system and Cav1.2 Ca2+ channels in ACC. Nature Neurosci 2010, 13: 482\u2013488.","journal-title":"Nature Neuroscience"},{"key":"378_CR42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12264-017-0139-9","volume":"34","author":"M Anderson","year":"2018","unstructured":"Anderson M, Zheng Q, Dong X. Investigation of pain mechanisms by calcium imaging approaches. Neurosci Bull 2018, 34: 194\u2013199.","journal-title":"Neurosci Bull"},{"key":"378_CR43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4196\/kjpp.2010.14.1.45","volume":"14","author":"F Zhi","year":"2010","unstructured":"Zhi F, Hwang JH, Kim JS, Jung SJ, Oh SB. R-type calcium channel isoform in rat dorsal root ganglion neurons. Korean J Physiol Pharmacol 2010, 14: 45\u201349.","journal-title":"Korean J Physiol Pharmacol"},{"key":"378_CR44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ceca.2009.08.001","volume":"46","author":"L Yang","year":"2009","unstructured":"Yang L, Stephens GJ. Effects of neuropathy on high-voltage-activated Ca2+ current in sensory neurons. Cell Calcium 2009, 46: 248\u2013256.","journal-title":"Cell Calcium"},{"key":"378_CR45","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1073\/pnas.100124197","volume":"97","author":"H Saegusa","year":"2000","unstructured":"Saegusa H, Kurihara T, Zong S, Minowa O, Kazuno A, Han W, et al. Altered pain responses in mice lacking alpha 1E subunit of the voltage-dependent Ca2+ channel. Proc Natl Acad Sci U S A 2000, 97: 6132\u20136137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"378_CR46","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1523\/JNEUROSCI.5342-10.2011","volume":"31","author":"MD Mark","year":"2011","unstructured":"Mark MD, Maejima T, Kuckelsberg D, Yoo JW, Hyde RA, Shah V, et al. Delayed postnatal loss of P\/Q-type calcium channels recapitulates the absence epilepsy, dyskinesia, and ataxia phenotypes of genomic Cacna1a mutations. J Neurosci 2011, 31: 4311\u20134326.","journal-title":"J Neurosci"},{"issue":"3","key":"378_CR47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.neuroscience.2006.06.049","volume":"142","author":"S. Luvisetto","year":"2006","unstructured":"Luvisetto S, Marinelli S, Panasiti MS, D\u2019Amato FR, Fletcher CF, Pavone F, et al. Pain sensitivity in mice lacking the Ca(v)2.1alpha1 subunit of P\/Q-type Ca2+ channels. Neuroscience 2006, 142: 823\u2013832.","journal-title":"Neuroscience"},{"key":"378_CR48","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1213\/ANE.0b013e318249d36e","volume":"115","author":"H Clarke","year":"2012","unstructured":"Clarke H, Bonin RP, Orser BA, Englesakis M, Wijeysundera DN, Katz J. The prevention of chronic postsurgical pain using gabapentin and pregabalin: a combined systematic review and meta-analysis. Anesth Analg 2012, 115: 428\u2013442.","journal-title":"Anesth Analg"},{"key":"378_CR49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2011.05.054","volume":"667","author":"Z Li","year":"2011","unstructured":"Li Z, Taylor CP, Weber M, Piechan J, Prior F, Bian F, et al. Pregabalin is a potent and selective ligand for \u03b12\u03b4-1 and \u03b12\u03b4-2 calcium channel subunits. Eur J Pharmacol 2011, 667 : 80\u201390.","journal-title":"Eur J Pharmacol"},{"key":"378_CR50","doi-asserted-by":"crossref","first-page":"16412","DOI":"10.1523\/JNEUROSCI.1026-13.2013","volume":"33","author":"R Patel","year":"2013","unstructured":"Patel R, Bauer CS, Nieto-Rostro M, Margas W, Ferron L, Chaggar K, et al. alpha2delta-1 gene deletion affects somatosensory neuron function and delays mechanical hypersensitivity in response to peripheral nerve damage. J Neurosci 2013, 33: 16412\u201316426.","journal-title":"J Neurosci"},{"key":"378_CR51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neulet.2014.07.033","volume":"584","author":"JE Biggs","year":"2015","unstructured":"Biggs JE, Stemkowski PL, Knaus EE, Chowdhury MA, Ballanyi K, Smith PA. Suppression of network activity in dorsal horn by gabapentin permeation of TRPV1 channels: implications for drug access to cytoplasmic targets. Neurosci Lett 2015, 584: 397\u2013402.","journal-title":"Neurosci Lett"},{"key":"378_CR52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1073858416628793","volume":"23","author":"SRA Alles","year":"2016","unstructured":"Alles SRA, Smith PA. The anti-allodynic gabapentinoids: myths, paradoxes, and acute effects. Neuroscientist 2016, 23: 40\u201355.","journal-title":"Neuroscientist"},{"key":"378_CR53","doi-asserted-by":"crossref","unstructured":"Wiffen PJ, Derry S, Bell RF, Rice AS, T\u00f6lle TR, Phillips T, et al. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2017, 6: CD007938.","DOI":"10.1002\/14651858.CD007938.pub4"},{"key":"378_CR54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12264-015-0008-3","volume":"32","author":"Y Yang","year":"2016","unstructured":"Yang Y, Yang F, Yang F, Li CL, Wang Y, Li Z, et al. Gabapentinoid insensitivity after repeated administration is associated with downregulation of the \u03b12\u03b4-1 subunit in rats with central post-stroke pain hypersensitivity. Neurosci Bull 2016, 32: 41\u201350.","journal-title":"Neurosci Bull"},{"key":"378_CR55","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1097\/j.pain.0000000000000608","volume":"157","author":"M Kimura","year":"2016","unstructured":"Kimura M, Eisenach JC, Hayashida K. Gabapentin loses efficacy over time after nerve injury in rats: role of glutamate transporter-1 in the locus coeruleus. Pain 2016, 157: 2024\u20132032.","journal-title":"Pain"},{"key":"378_CR56","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bcp.2011.10.019","volume":"83","author":"VE Scott","year":"2012","unstructured":"Scott VE, Vortherms TA, Niforatos W, Swensen AM, Neelands T, Milicic I, et al. A-1048400 is a novel, orally active, state-dependent neuronal calcium channel blocker that produces dose-dependent antinociception without altering hemodynamic function in rats. Biochem Pharmacol 2012, 83: 406\u2013418.","journal-title":"Biochem Pharmacol"},{"key":"378_CR57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neuropharm.2016.10.016","volume":"127","author":"E Bourinet","year":"2017","unstructured":"Bourinet E, Zamponi GW. Block of voltage-gated calcium channels by peptide toxins. Neuropharmacology 2017, 127: 109\u2013115.","journal-title":"Neuropharmacology"},{"key":"378_CR58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/md15100313","volume":"15","author":"D Ram\u00edrez","year":"2017","unstructured":"Ram\u00edrez D, Gonzalez W, Fissore RA, Carvacho I. Conotoxins as Tools to Understand the Physiological Function of Voltage-Gated Calcium (Cav) Channels. Mar Drugs 2017, 15: 313.","journal-title":"Mar Drugs"},{"key":"378_CR59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0014-2999(02)02247-1","volume":"451","author":"DA Scott","year":"2002","unstructured":"Scott DA, Wright CE, Angus JA. Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. Eur J Pharmacol 2002, 451: 279\u2013286.","journal-title":"Eur J Pharmacol"},{"key":"378_CR60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1570159X14666160210142056","volume":"15","author":"ME Brookes","year":"2017","unstructured":"Brookes ME, Eldabe S, Batterham A. Ziconotide Monotherapy: A systematic review of randomised controlled trials. Curr Neuropharmacol 2017, 15: 217\u2013231.","journal-title":"Curr Neuropharmacol"},{"key":"378_CR61","first-page":"727","volume":"74","author":"V Vitale","year":"2008","unstructured":"Vitale V, Battelli D, Gasperoni E, Monachese N. Intrathecal therapy with ziconotide: clinical experience and considerations on its use. Minerva Anestesiol. 2008, 74: 727\u2013733.","journal-title":"Minerva Anestesiol."},{"key":"378_CR62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1525-1403.2008.00150.x","volume":"11","author":"A Ver Donck","year":"2008","unstructured":"Ver Donck A, Collins R, Rauck RL, Nitescu P. An open-label, multicenter study of the safety and efficacy of intrathecal ziconotide for severe chronic pain when delivered via an external pump. Neuromodulation 2008, 11: 103\u2013111.","journal-title":"Neuromodulation"},{"key":"378_CR63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1525-1403.2005.05232.x","volume":"8","author":"R Fisher","year":"2005","unstructured":"Fisher R, Hassenbusch S, Krames E, Leong M, Minehart M, Prager J, et al. A consensus statement regarding the present suggested titration for prialt (ziconotide). Neuromodulation 2005, 8: 153\u2013154.","journal-title":"Neuromodulation"},{"key":"378_CR64","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1525-1403.2012.00476.x","volume":"15","author":"TR Deer","year":"2012","unstructured":"Deer TR, Prager J, Levy R, Rathmell J, Buchser E, Burton A, et al. Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 2012, 15: 436\u2013466.","journal-title":"Neuromodulation"},{"key":"378_CR65","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1021\/acs.biochem.8b00803","volume":"57","author":"M Dong","year":"2018","unstructured":"Dong M, Wang F, Yan Z, Yu S, Wei J, Wu Q, et al. Structure-activity analysis of N-type calcium channel inhibitor SO-3. Biochemistry 2018, 57: 6349\u20136355.","journal-title":"Biochemistry"},{"key":"378_CR66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2010.03.036","volume":"636","author":"LD Yan","year":"2010","unstructured":"Yan LD, Liu YL, Zhang L, Dong HJ, Zhou PL, Su RB, et al. Spinal antinociception of synthetic omega-conotoxin SO-3, a selective N-type neuronal voltage-sensitive calcium channel blocker, and its effects on morphine analgesia in chemical stimulus tests in rodent. Eur J Pharmacol 2010, 636: 73\u201381.","journal-title":"Eur J Pharmacol"},{"key":"378_CR67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2015.01.054","volume":"1605","author":"Shuzhuo Zhang","year":"2015","unstructured":"Zhang S, Yang L, Zhang K, Liu X, Dai W, Zhang C, et al. ZC88, a novel N-type calcium channel blocker from 4-amino-piperidine derivatives state-dependent inhibits Cav2.2 calcium channels. Brain Res 2015, 1605: 12\u201321.","journal-title":"Brain Research"},{"key":"378_CR68","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1124\/jpet.110.166363","volume":"334","author":"C Abbadie","year":"2010","unstructured":"Abbadie C, McManus OB, Sun SY, Bugianesi RM, Dai G, Haedo RJ, et al. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker. J. Pharmacol Exp Ther 2010, 334: 545\u2013555.","journal-title":"J. Pharmacol Exp Ther"},{"key":"378_CR69","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2008.02.066","volume":"586","author":"G Meng","year":"2008","unstructured":"Meng G, Wu N, Zhang C, Su RB, Lu XQ, Liu Y, et al. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence. Eur J Pharmacol 2008, 586: 130\u2013138.","journal-title":"Eur J Pharmacol"},{"key":"378_CR70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuroscience.2015.03.057","volume":"297","author":"R Patel","year":"2015","unstructured":"Patel R, Rutten K, Valdor M, Schiene K, Wigge S, Schunk S, et al. Electrophysiological characterization of activation statedependent Ca(v)2 channel antagonist TROX-1 in spinal nerve injured rats. Neuroscience 2015, 297: 47\u201357.","journal-title":"Neuroscience"},{"key":"378_CR71","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1016\/j.bmc.2018.03.031","volume":"26","author":"A Sairaman","year":"2018","unstructured":"Sairaman A, Cardoso FC, Bispat A, Lewis RJ, Duggan PJ, Tuck KL. Synthesis and evaluation of aminobenzothiazoles as blockers of N- and T-type calcium channels. Bioorg Med Chem 2018, 26: 3046\u20133059.","journal-title":"Bioorg Med Chem"},{"key":"378_CR72","doi-asserted-by":"crossref","first-page":"41504","DOI":"10.1074\/jbc.M007165200","volume":"275","author":"S Yamaguchi","year":"2000","unstructured":"Yamaguchi S, Okamura Y, Nagao T, Adachi-Akahane S. Serine residue in the IIIS5-S6 linker of the L-type Ca2+ channel alpha 1C subunit is the critical determinant of the action of dihydropyridine Ca2+ channel agonists. J Biol Chem 2000, 275: 41504\u201341511.","journal-title":"J Biol Chem"},{"key":"378_CR73","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1523\/JNEUROSCI.3145-09.2010","volume":"30","author":"P Fossat","year":"2010","unstructured":"Fossat P, Dobremez E, Bouali-Benazzouz R, Favereaux A, Bertrand SS, Kilk K, et al. Knockdown of L calcium channel subtypes: differential effects in neuropathic pain. J Neurosci 2010, 30: 1073\u20131085.","journal-title":"J Neurosci"},{"key":"378_CR74","doi-asserted-by":"crossref","unstructured":"Kang S, Cooper G, Dunne SF, Dusel B, Luan CH, Surmeier DJ, et al. Cav1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson\u2019s disease. Nat Commun 2012, 3: 1146.","DOI":"10.1038\/ncomms2149"},{"key":"378_CR75","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1038\/ncomms4897","volume":"5","author":"NJ Ortner","year":"2014","unstructured":"Ortner NJ, Bock G, Vandael DH, Mauersberger R, Draheim HJ, Gust R, et al. Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. Nat Commun 2014, 5: 3897.","journal-title":"Nat Commun"},{"key":"378_CR76","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2174\/1570159X11311060005","volume":"11","author":"S Lee","year":"2013","unstructured":"Lee S. Pharmacological inhibition of voltage-gated Ca(2+) channels for chronic pain relief. Curr Neuropharmacol 2013, 11: 606\u2013620.","journal-title":"Curr Neuropharmacol"},{"key":"378_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.06.018","volume":"75","author":"T Terashima","year":"2013","unstructured":"Terashima T, Xu Q, Yamaguchi S, Yaksh TL. Intrathecal P\/Q- and R-type calcium channel blockade of spinal substance P release and c-Fos expression. Neuropharmacology 2013, 75: 1\u20138.","journal-title":"Neuropharmacology"},{"issue":"12","key":"378_CR78","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1111\/j.1460-9568.2007.05605.x","volume":"25","author":"Elizabeth A. Matthews","year":"2007","unstructured":"Matthews EA, Bee LA, Stephens GJ, Dickenson AH. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain. Eur J Neurosci 2007, 25: 3561\u20133569.","journal-title":"European Journal of Neuroscience"},{"key":"378_CR79","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1111\/j.1460-9568.1997.tb01386.x","volume":"9","author":"J Nebe","year":"1997","unstructured":"Nebe J, Vanegas H, Neugebauer V, Schaible HG. Omega-agatoxin IVA, a P-type calcium channel antagonist, reduces nociceptive processing in spinal cord neurons with input from the inflamed but not from the normal knee joint\u2013an electrophysio-logical study in the rat in vivo. Eur J Neurosci 1997, 9: 2193\u20132201.","journal-title":"Eur J Neurosci"},{"key":"378_CR80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/toxins3010017","volume":"3","author":"E Pringos","year":"2011","unstructured":"Pringos E, Vignes M, Martinez J, Rolland V. Peptide neurotoxins that affect voltage-gated calcium channels: a close-up on \u03c9-agatoxins. Toxins 2011, 3: 17\u201342.","journal-title":"Toxins"},{"key":"378_CR81","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0024-3205(03)00700-8","volume":"73","author":"T Fukuizumi","year":"2003","unstructured":"Fukuizumi T, Ohkubo T, Kitamura K. Spinally delivered N-, P\/Q- and L-type Ca2+-channel blockers potentiate morphine analgesia in mice. Life Sci. 2003, 73: 2873\u20132881.","journal-title":"Life Sci."},{"key":"378_CR82","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.pain.2011.04.015","volume":"152","author":"GD Dalmolin","year":"2011","unstructured":"Dalmolin GD, Silva CR, Rigo FK, Gomes GM, Cordeiro Mdo N, Richardson M, et al. Antinociceptive effect of Brazilian armed spider venom toxin Tx3-3 in animal models of neuropathic pain. Pain 2011, 152: 2224\u20132232.","journal-title":"Pain"},{"key":"378_CR83","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nmeth.1514","volume":"7","author":"B Anliker","year":"2010","unstructured":"Anliker B, Abel T, Kneissl S, Hlavaty J, Caputi A, Brynza J, et al. Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors. Nat Methods 2010, 7: 929\u2013935.","journal-title":"Nat Methods"},{"key":"378_CR84","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1097\/j.pain.0000000000001060","volume":"158","author":"D Clauw","year":"2017","unstructured":"Clauw D. Hijacking the endogenous opioid system to treat pain: who thought it would be so complicated? Pain 2017, 158: 2283\u20132284.","journal-title":"Pain"},{"key":"378_CR85","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.22267","volume":"66","author":"MA Fitzcharles","year":"2014","unstructured":"Fitzcharles MA, Clauw DJ, Ste-Marie PA, Shir Y. The dilemma of medical marijuana use by rheumatology patients. Arthritis Care Res (Hoboken). 2014, 66: 797\u2013801.","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"378_CR86","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/00000542-200312000-00019","volume":"99","author":"K Yokoyama","year":"2003","unstructured":"Yokoyama K, Kurihara T, Makita K, Tanabe T. Plastic change of N-type Ca channel expression after preconditioning is responsible for prostaglandin E2-induced long-lasting allodynia. Anesthesiology 2003, 99: 1364\u20131370.","journal-title":"Anesthesiology"},{"key":"378_CR87","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.pain.2010.08.030","volume":"151","author":"SG Lu","year":"2010","unstructured":"Lu SG, Zhang XL, Luo ZD, Gold MS. Persistent inflammation alters the density and distribution of voltage-activated calcium channels in subpopulations of rat cutaneous DRG neurons. Pain 2010, 151: 633\u2013643.","journal-title":"Pain"},{"key":"378_CR88","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00221-002-1217-3","volume":"147","author":"D Cizkova","year":"2002","unstructured":"Cizkova D, Marsala J, Lukacova N, Marsala M, Jergova S, Orendacova J, et al. Localization of N-type Ca2+ channels in the rat spinal cord following chronic constrictive nerve injury. Exp Brain Res 2002, 147: 456\u2013463.","journal-title":"Exp Brain Res"},{"key":"378_CR89","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pain.2008.05.004","volume":"139","author":"A Boroujerdi","year":"2008","unstructured":"Boroujerdi A, Kim HK, Lyu YS, Kim DS, Figueroa KW, Chung JM, et al. Injury discharges regulate calcium channel alpha-2-delta-1 subunit upregulation in the dorsal horn that contributes to initiation of neuropathic pain. Pain 2008, 139: 358\u2013366.","journal-title":"Pain"},{"key":"378_CR90","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2016.11.003","volume":"288","author":"M Leo","year":"2017","unstructured":"Leo M, Schmitt LI, Erkel M, Melnikova M, Thomale J, Hagenacker T. Cisplatin-induced neuropathic pain is mediated by upregulation of N-type voltage-gated calcium channels in dorsal root ganglion neurons. Exp Neurol 2017, 288: 62\u201374.","journal-title":"Exp Neurol"},{"key":"378_CR91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1744-8069-9-15","volume":"9","author":"A Qian","year":"2013","unstructured":"Qian A, Song D, Li Y, Liu X, Tang D, Yao W, et al. Role of voltage gated Ca2+ channels in rat visceral hypersensitivity change induced by 2,4,6-trinitrobenzene sulfonic acid. Mol Pain 2013, 9: 15.","journal-title":"Mol Pain"},{"key":"378_CR92","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00424-014-1620-1","volume":"467","author":"R Nishimoto","year":"2015","unstructured":"Nishimoto R, Kashio M, Tominaga M. Propofol-induced pain sensation involves multiple mechanisms in sensory neurons. Pflugers Arch. 2015, 467: 2011\u20132020.","journal-title":"Pflugers Arch."},{"key":"378_CR93","doi-asserted-by":"crossref","first-page":"174480691876580","DOI":"10.1177\/1744806918765806","volume":"14","author":"SR Alles","year":"2018","unstructured":"Alles SR, Garcia E, Balasubramanyan S, Jones K, Tyson JR, Joy T, et al. Peripheral nerve injury increases contribution of L-type calcium channels to synaptic transmission in spinal lamina II: Role of \u03b12\u03b4-1 subunits. Mol Pain 2018, 14: 1744806918765806.","journal-title":"Mol Pain"},{"key":"378_CR94","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1111\/j.1460-9568.2005.04177.x","volume":"21","author":"E Dobremez","year":"2005","unstructured":"Dobremez E, Bouali-Benazzouz R, Fossat P, Monteils L, Dulluc J, Nagy F, et al. Distribution and regulation of L-type calcium channels in deep dorsal horn neurons after sciatic nerve injury in rats. Eur J Neurosci 2005, 21: 3321\u20133333.","journal-title":"Eur J Neurosci"},{"key":"378_CR95","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1744-8069-8-7","volume":"8","author":"T Kawashiri","year":"2012","unstructured":"Kawashiri T, Egashira N, Kurobe K, Tsutsumi K, Yamashita Y, Ushio S, et al. L type Ca2+ channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats. Mol Pain 2012, 8: 7.","journal-title":"Mol Pain"},{"issue":"9","key":"378_CR96","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/j.pain.0000000000000971","volume":"158","author":"Jagadeesh Gandla","year":"2017","unstructured":"Gandla J, Lomada SK, Lu J, Kuner R, Bali KK. miR-34c-5p functions as pronociceptive microRNA in cancer pain by targeting Cav2.3 containing calcium channels. Pain 2017, 158: 1765\u20131779.","journal-title":"PAIN"},{"key":"378_CR97","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0304-3959(96)03271-X","volume":"69","author":"A Diaz","year":"1997","unstructured":"Diaz A, Dickenson AH. Blockade of spinal N- and P-type, but not L-type, calcium channels inhibits the excitability of rat dorsal horn neurones produced by subcutaneous formalin inflammation. Pain 1997, 69: 93\u2013100.","journal-title":"Pain"},{"key":"378_CR98","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/bbrc.2001.5943","volume":"289","author":"SP Yusaf","year":"2001","unstructured":"Yusaf SP, Goodman J, Gonzalez IM, Bramwell S, Pinnock RD, Dixon AD, et al. Streptozocin-induced neuropathy is associated with altered expression of voltage-gated calcium channel subunit mRNAs in rat dorsal root ganglion neurons. Biochem Biophys Res Commun 2001, 289: 402\u2013406.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-019-00378-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-019-00378-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-019-00378-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T23:37:08Z","timestamp":1588721828000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-019-00378-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["378"],"URL":"https:\/\/doi.org\/10.1007\/s12264-019-00378-5","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]},"assertion":[{"value":"7 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}